BACKGROUND: Genetic variants in myocardial sodium and potassium channel genes are associated with prolonged QT interval and increased risk of sudden death. It is unclear whether these genetic variants remain relevant in subjects with underlying conditions such as diabetes that are associated with prolonged QT interval. METHODS: We tested single nucleotide polymorphisms (SNPs) in five candidate genes for association with QT interval in a family-based study of subjects with type 2 diabetes mellitus (T2DM). Thirty-six previously reported SNPs were genotyped in KCNQ1, HERG, SCN5A, KCNE1, and KCNE2 in 901 European Americans from 366 families. The heart rate-corrected (QTc) durations were determined using the Marquette 12SL program. Associations between the QTc interval and the genotypes were evaluated using SOLAR adjusting for age, gender, T2DM status, and body mass index. RESULTS: Within KCNQ1 there was weak evidence for association between the minor allele of IVS12 +14T>C and increased QTc (P = 0.02). The minor allele of rs2236609 in KCNE1 trended toward significance with longer QTc (P = 0.06), while the minor allele of rs1805123 in HERG trended toward significance with shorter QTc (P = 0.07). However, no statistically significant associations were observed between the remaining SNPs and QTc variation. CONCLUSIONS: We found weak evidence of association between three previously reported SNPs and QTc interval duration. While it appears as though genetic variants in previously identified candidate genes may be associated with QT duration in subjects with diabetes, the clinical implications of these associations in diabetic subjects at high risk for sudden death remain to be determined.
BACKGROUND: Genetic variants in myocardial sodium and potassium channel genes are associated with prolonged QT interval and increased risk of sudden death. It is unclear whether these genetic variants remain relevant in subjects with underlying conditions such as diabetes that are associated with prolonged QT interval. METHODS: We tested single nucleotide polymorphisms (SNPs) in five candidate genes for association with QT interval in a family-based study of subjects with type 2 diabetes mellitus (T2DM). Thirty-six previously reported SNPs were genotyped in KCNQ1, HERG, SCN5A, KCNE1, and KCNE2 in 901 European Americans from 366 families. The heart rate-corrected (QTc) durations were determined using the Marquette 12SL program. Associations between the QTc interval and the genotypes were evaluated using SOLAR adjusting for age, gender, T2DM status, and body mass index. RESULTS: Within KCNQ1 there was weak evidence for association between the minor allele of IVS12 +14T>C and increased QTc (P = 0.02). The minor allele of rs2236609 in KCNE1 trended toward significance with longer QTc (P = 0.06), while the minor allele of rs1805123 in HERG trended toward significance with shorter QTc (P = 0.07). However, no statistically significant associations were observed between the remaining SNPs and QTc variation. CONCLUSIONS: We found weak evidence of association between three previously reported SNPs and QTc interval duration. While it appears as though genetic variants in previously identified candidate genes may be associated with QT duration in subjects with diabetes, the clinical implications of these associations in diabetic subjects at high risk for sudden death remain to be determined.
Authors: Arne Pfeufer; Shapour Jalilzadeh; Siegfried Perz; Jakob C Mueller; Martin Hinterseer; Thomas Illig; Mahmut Akyol; Cornelia Huth; Andreas Schöpfer-Wendels; Bernhard Kuch; Gerhard Steinbeck; Rolf Holle; Michael Näbauer; H-Erich Wichmann; Thomas Meitinger; Stefan Kääb Journal: Circ Res Date: 2005-03-03 Impact factor: 17.367
Authors: Leslie A Lange; Ethan M Lange; Lawrence F Bielak; Carl D Langefeld; Sharon L Kardia; Patrick Royston; Stephen T Turner; Patrick F Sheedy; Eric Boerwinkle; Patricia A Peyser Journal: Arterioscler Thromb Vasc Biol Date: 2002-03-01 Impact factor: 8.311
Authors: Ping Yang; Hideaki Kanki; Benoit Drolet; Tao Yang; Jian Wei; Prakash C Viswanathan; Stefan H Hohnloser; Wataru Shimizu; Peter J Schwartz; Marshall Stanton; Katherine T Murray; Kris Norris; Alfred L George; Dan M Roden Journal: Circulation Date: 2002-04-23 Impact factor: 29.690
Authors: Michael J Ackerman; David J Tester; Gregg S Jones; Melissa L Will; Christopher R Burrow; Mark E Curran Journal: Mayo Clin Proc Date: 2003-12 Impact factor: 7.616
Authors: Eeva Pietilä; Heidi Fodstad; Elmo Niskasaari; Päivi J Laitinen P; Heikki Swan; Markku Savolainen; Y Antero Kesäniemi; Kimmo Kontula; Heikki V Huikuri Journal: J Am Coll Cardiol Date: 2002-08-07 Impact factor: 24.094
Authors: K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun Journal: Proc Natl Acad Sci U S A Date: 2001-01-02 Impact factor: 11.205
Authors: Donald W Bowden; Amanda J Cox; Barry I Freedman; Christina E Hugenschimdt; Lynne E Wagenknecht; David Herrington; Subhashish Agarwal; Thomas C Register; Joseph A Maldjian; Maggie C-Y Ng; Fang-Chi Hsu; Carl D Langefeld; Jeff D Williamson; J Jeffrey Carr Journal: Rev Diabet Stud Date: 2010-11-10
Authors: Amanda J Cox; Christina E Hugenschmidt; Patty T Wang; Fang-Chi Hsu; Satish Kenchaiah; Kurt Daniel; Carl D Langefeld; Barry I Freedman; David M Herrington; J Jeffrey Carr; Brandon Stacey; Donald W Bowden Journal: Am J Cardiol Date: 2013-01-23 Impact factor: 2.778
Authors: Young Soo Lee; Michael A Olaopa; Byung Chun Jung; Sang Hee Lee; Dong Gu Shin; Hyoung Seob Park; Yongkeun Cho; Sang Mi Han; Myung Hoon Lee; Yoon Nyun Kim Journal: Korean Circ J Date: 2016-01-14 Impact factor: 3.243